About Curt LaBelle
Form D filings for Vedanta Biosciences from 2023 to 2024 list Curt LaBelle as director.
Curt LaBelle first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Curt LaBelle in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Curt LaBelle works with at each company, as listed on that company's latest Form D.
Vedanta Biosciences, Inc. · Form D/A, Aug 5, 2024
JL
John LaMattina
Director
CS
Charles Sherwood
Director
SD
Susan Dillon
Director
MH
Martin Heidecker
Director
NT
Neil Tiwari
Director
DC
Daniel Couto
Executive officer
BO
Bernat Olle
Executive officer and director
MM
Mark Mullikin
Treasurer
BS
Bennett Shapiro
Director
TI
Troy Ignelzi
Director
JS
Jeffrey Silber
Executive officer